as 05-30-2025 3:42pm EST
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Founded: | 1943 | Country: | United States |
Employees: | N/A | City: | WAYNE |
Market Cap: | 5.3B | IPO Year: | N/A |
Target Price: | $176.50 | AVG Volume (30 days): | 495.0K |
Analyst Decision: | Hold | Number of Analysts: | 10 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 3.20 | EPS Growth: | -48.69 |
52 Week Low/High: | $119.08 - $249.91 | Next Earning Date: | 05-01-2025 |
Revenue: | $3,010,144,000 | Revenue Growth: | 0.29% |
Revenue Growth (this year): | 2.88% | Revenue Growth (next year): | 4.85% |
TFX Breaking Stock News: Dive into TFX Ticker-Specific Updates for Smart Investing
StockStory
4 days ago
StockStory
11 days ago
GlobeNewswire
13 days ago
Simply Wall St.
16 days ago
GlobeNewswire
17 days ago
StockStory
17 days ago
Argus Research
18 days ago
GlobeNewswire
19 days ago
The information presented on this page, "TFX Teleflex Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.